AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2018

Nov 26, 2018

33081_dirs_2018-11-26_c61d2e7b-fa9f-4728-b5a9-d58d3fabfa9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2018-11-23

Reporting Person: Colonno Richard James (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-23	Common Stock	A	25000	—	Acquired	90000	Direct

Footnotes

F1: Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On November 23, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock.